Macrophage colony-stimulating factor (M-CSF) augments cytokine induction by lipopolysaccharide (LPS)-stimulation and by bacterial infections in mice

被引:14
作者
Hanamura, T [1 ]
Asakura, E [1 ]
Tanabe, T [1 ]
机构
[1] GREEN CROSS CO,CENT RES LAB,HIRAKATA,OSAKA 573,JAPAN
来源
IMMUNOPHARMACOLOGY | 1997年 / 37卷 / 01期
关键词
macrophage colony-stimulating factor; priming; lipopolysaccharide; monokine;
D O I
10.1016/S0162-3109(96)00166-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the effects of M-CSF on cytokine induction in vivo by LPS or by bacterial infection by comparing between the serum cytokine levels of mice administered with and without M-CSF. M-CSF at 250 mu g/kg/day for 3 days significantly augmented serum IL-6 level induced by a subsequent injection of 25 mu g/kg of LPS. The augmented IL-B-induction was dose-dependent from 50 to 1250 mu g/kg/day of M-CSF, and required 2- to 3-doses of M-CSF at 250 mu g/kg/day. Mice primed with M-CSF induced IL-6 in response to a 5-fold lower dose of LPS, and also produced higher levels of IL-1 alpha, IL-10, GM-CSF, TNF-alpha, and IFN-gamma than control mice. The priming effect of M-CSF was transient and reversible, and elicited independently of T-cells. An injection with intact bacteria, such as Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus also induced IL-6 in normal mice, and M-CSF administration augmented the induction of these cytokines. These results showed that M-CSF positively regulates LPS-dependent and -independent cytokine induction, suggesting a defensive effect against infectious agents through enhanced cytokine production. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 41 条
[1]   Effects of macrophage colony-stimulating factor (M-CSF) on lipopolysaccharide (LPS)-induced mediator production from monocytes in vitro [J].
Asakura, E ;
Hanamura, T ;
Umemura, A ;
Yada, K ;
Yamauchi, T ;
Tanabe, T .
IMMUNOBIOLOGY, 1996, 195 (03) :300-313
[2]  
BERMUDEZ LEM, 1988, J IMMUNOL, V140, P3006
[3]  
BLACK CM, 1987, J IMMUNOL, V138, P491
[4]   MACROPHAGE COLONY-STIMULATING FACTOR IN MURINE CANDIDIASIS - SERUM AND TISSUE-LEVELS DURING INFECTION AND PROTECTIVE EFFECT OF EXOGENOUS ADMINISTRATION [J].
CENCI, E ;
BARTOCCI, A ;
PUCCETTI, P ;
MOCCI, S ;
STANLEY, ER ;
BISTONI, F .
INFECTION AND IMMUNITY, 1991, 59 (03) :868-872
[5]   THE HUMAN HEMATOPOIETIC COLONY-STIMULATING FACTORS [J].
CLARK, SC ;
KAMEN, R .
SCIENCE, 1987, 236 (4806) :1229-1237
[6]  
COCKFIELD SM, 1993, J IMMUNOL, V150, P342
[7]  
CZUPRYNSKI CJ, 1988, J IMMUNOL, V140, P962
[8]   PROTECTION OF MICE AGAINST LISTERIA-MONOCYTOGENES INFECTION BY RECOMBINANT HUMAN-TUMOR NECROSIS FACTOR-ALPHA [J].
DESIDERIO, JV ;
KIENER, PA ;
LIN, PF ;
WARR, GA .
INFECTION AND IMMUNITY, 1989, 57 (05) :1615-1617
[9]   SYNERGISTIC INTERACTION OF BACTERIAL LIPOPOLYSACCHARIDE AND THE MONOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - POTENTIAL QUANTITATIVE AND QUALITATIVE CHANGES IN MACROPHAGE-PRODUCED CYTOKINE BIOACTIVITY [J].
EVANS, R ;
KAMDAR, SJ ;
DUFFY, TM ;
FULLER, J .
JOURNAL OF LEUKOCYTE BIOLOGY, 1992, 51 (01) :93-96
[10]  
FUJITA H, 1995, J JAP ASS INFECT DIS, V69, P60